Mavacamten for hypertrophic obstructive cardiomyopathy

Lancet. 2021 Jan 30;397(10272):369. doi: 10.1016/S0140-6736(20)32384-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzylamines*
  • Cardiomyopathy, Hypertrophic* / diagnosis
  • Double-Blind Method
  • Humans
  • Uracil / analogs & derivatives

Substances

  • Benzylamines
  • MYK-461
  • Uracil